-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Grass in Allergic Rhino-Conjunctivitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pollinex Quattro Grass in Allergic Rhino-Conjunctivitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pollinex Quattro Grass in Allergic Rhino-Conjunctivitis Drug Details: Pollinex...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VLP-001 in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VLP-001 in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VLP-001 in Peanut Allergy Drug Details: Polyvac peanut vaccine is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Tree in Pollen Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pollinex Quattro Tree in Pollen Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Pollinex Quattro Tree in Pollen AllergyDrug Details:TreeMATA MPL is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vaccine For Grass Pollen Allergy And House Dust Mite Allergy in House Dust Mite Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vaccine For Grass Pollen Allergy And House Dust Mite Allergy in House Dust Mite Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Vaccine For...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTC-011 in Otitis Externa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTC-011 in Otitis Externa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NTC-011 in Otitis ExternaDrug Details:NTC-011 is under development for the treatment of otitis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STMC-103H in Wheezing
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STMC-103H in Wheezing report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.STMC-103H in WheezingDrug Details:STMC-103H is under development for the treatment and prevention of atopic...
-
Product Insights
Allergic Rhino-Conjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Allergic Rhino-Conjunctivitis Clinical Trials Market Report Overview The Allergic Rhino-Conjunctivitis clinical trial market research report provides an overview of the Allergic Rhino-Conjunctivitis clinical trials scenario. This report provides top-line data relating to the clinical trials on Allergic Rhino-Conjunctivitis and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Company Profile
Allergy Therapeutics Plc – Company Profile
Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers aluminum-free allergy vaccines and diagnostics. Allergy Therapeutics product portfolio includes Grass Modified Allergen Tyrosine Adsorbed (MATA), Tree MATA, Ragweed MATA, Bee Venom Subcutaneous Immunotherapy (SCIT), and Wasp venom SCIT among others. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise Pollen, Moulds, Arthropods, Epithelia and others. It has an operational presence in...
Add to Basket -
Product Insights
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. The Melanoma pipeline market research report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.